Diagnosis & Disease Information

Watson Confirms Filing of Generic Version of Beyaz

Watson Pharmaceuticals, Inc. confirmed that it has filed with the FDA an Abbreviated New Drug Application (ANDA) for Drospirenone and Ethinyl Estradiol and Levomefolate Calcium Tablets, 3.0mg/0.02mg/0.451mg and Levomefolate Calcium Tablets, 0.451mg, a generic version of Bayer HealthCare Pharmaceuticals Inc.’s Beyaz.

SKLICE (ivermectin) 0.5% lotion by Sanofi

Sklice Lotion Approved for Head Lice

Sanofi announced that the FDA has approved Sklice (ivermectin lotion) 0.5% for the topical treatment of head lice in patients ≥6 months of age.

Mylan Acquires Two Dermatological Products from Valeant

Mylan announced that it has acquired the abbreviated new drug application (ANDA) for Clindamycin Phosphate / Benzoyl Peroxide gel, the generic version of Valeant’s BenzaClin, and a license to manufacture and market Fluorouracil 5%, the generic version of Valeant’s Efudex Cream.

ERIVEDGE (vismodegib) 150mg capsules by Genentech

Erivedge Approved for Advanced Basal Cell Carcinoma

Genentech announced that the FDA has approved Erivedge (vismodegib capsules) for the treatment of adults with advanced basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.